Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 4/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | TK1 | P04183 | 1/20 | 0.44 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.44 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.44 |
| ▸ | PDE7B | Q9NP56 | 2/20 | 0.44 |
| ▸ | XDH | P47989 | 3/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EDNRA | P25101 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | STING1 | Q86WV6 | 3/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21000304 | 0.81 | ADORA3 (0.53) | PNPADORA3TK1HPRT1USP2 | |
| SCHEMBL13558732 | 0.81 | ADORA3 (0.53) | PNPADORA3TK1HPRT1USP2 | |
| SCHEMBL7508815 | 0.81 | PDE7A (0.66) | PNPADORA3HPRT1PDE7APDE7B | |
| SCHEMBL9153582 | 0.81 | PNP (0.48) | PNPADORA3TK1HPRT1XDH | |
| SCHEMBL14743926 | 0.79 | GRIA1 (0.62) | PNPADORA3HPRT1XDH | |
| SCHEMBL22107824 | 0.78 | PNP (0.47) | PNPADORA3TK1HPRT1XDH | |
| SCHEMBL15197991 | 0.77 | ADORA3 (0.51) | PNPADORA3TK1HPRT1USP2 | |
| SCHEMBL18516930 | 0.77 | ADORA3 (0.51) | PNPADORA3TK1HPRT1USP2 | |
| SCHEMBL13769965 | 0.77 | ADORA3 (0.46) | PNPADORA3TK1HPRT1XDH | |
| SCHEMBL880159 | 0.77 | ADORA3 (0.51) | PNPADORA3TK1HPRT1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2433941-A1 | Process for isolating the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | Bristol-Myers Squibb Company (US) | 2012-03-28 | — | — | EP | disclosed |
| WO-2007030657-A1 | CRYSTALLINE FORMS OF [1S-(1α, 3α, 4β)]-2- AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2- METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-03-15 | — | — | WO | disclosed |